These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 24584670)

  • 1. Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells.
    Bai X; Yang Q; Shu W; Wang J; Zhang L; Ma J; Xia S; Zhang M; Cheng S; Wang Y; Leng J
    Mol Med Rep; 2014 May; 9(5):1729-36. PubMed ID: 24584670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2 stimulates β1-integrin expression in hepatocellular carcinoma through the EP1 receptor/PKC/NF-κB pathway.
    Bai X; Wang J; Guo Y; Pan J; Yang Q; Zhang M; Li H; Zhang L; Ma J; Shi F; Shu W; Wang Y; Leng J
    Sci Rep; 2014 Oct; 4():6538. PubMed ID: 25289898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E₂ receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells.
    Bai X; Wang J; Zhang L; Ma J; Zhang H; Xia S; Zhang M; Ma X; Guo Y; Rong R; Cheng S; Shu W; Wang Y; Leng J
    Int J Oncol; 2013 May; 42(5):1833-41. PubMed ID: 23525457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 enhances alpha2beta1 integrin expression and cell migration via EP1 dependent signaling pathway in human chondrosarcoma cells.
    Liu JF; Fong YC; Chang CS; Huang CY; Chen HT; Yang WH; Hsu CJ; Jeng LB; Chen CY; Tang CH
    Mol Cancer; 2010 Feb; 9():43. PubMed ID: 20178602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells.
    Morello V; Cabodi S; Sigismund S; Camacho-Leal MP; Repetto D; Volante M; Papotti M; Turco E; Defilippi P
    Oncogene; 2011 Sep; 30(39):4087-96. PubMed ID: 21478906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 induced β1-integrin expression in NSCLC and promoted cell invasion via the EP1/MAPK/E2F-1/FoxC2 signal pathway.
    Pan J; Yang Q; Shao J; Zhang L; Ma J; Wang Y; Jiang BH; Leng J; Bai X
    Sci Rep; 2016 Sep; 6():33823. PubMed ID: 27654511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 suppresses beta1-integrin expression via E-prostanoid receptor in human monocytes/macrophages.
    Hasegawa S; Ichiyama T; Kohno F; Korenaga Y; Ohsaki A; Hirano R; Haneda Y; Fukano R; Furukawa S
    Cell Immunol; 2010; 263(2):161-5. PubMed ID: 20403585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EP1 receptor-mediated migration of the first trimester human extravillous trophoblast: the role of intracellular calcium and calpain.
    Nicola C; Timoshenko AV; Dixon SJ; Lala PK; Chakraborty C
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4736-46. PubMed ID: 15886234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta1 increases cell migration and beta1 integrin up-regulation in human lung cancer cells.
    Fong YC; Hsu SF; Wu CL; Li TM; Kao ST; Tsai FJ; Chen WC; Liu SC; Wu CM; Tang CH
    Lung Cancer; 2009 Apr; 64(1):13-21. PubMed ID: 18771813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shikonin attenuates lung cancer cell adhesion to extracellular matrix and metastasis by inhibiting integrin β1 expression and the ERK1/2 signaling pathway.
    Wang H; Wu C; Wan S; Zhang H; Zhou S; Liu G
    Toxicology; 2013 Jun; 308():104-12. PubMed ID: 23562787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific components of prostanoid-signaling pathways are present in non-small cell lung cancer cells.
    Kreutzer M; Fauti T; Kaddatz K; Seifart C; Neubauer A; Schweer H; Kömhoff M; Müller-Brüsselbach S; Müller R
    Oncol Rep; 2007 Aug; 18(2):497-501. PubMed ID: 17611676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
    Krysan K; Reckamp KL; Dalwadi H; Sharma S; Rozengurt E; Dohadwala M; Dubinett SM
    Cancer Res; 2005 Jul; 65(14):6275-81. PubMed ID: 16024629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.
    Kay LJ; Yeo WW; Peachell PT
    Br J Pharmacol; 2006 Apr; 147(7):707-13. PubMed ID: 16432506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells.
    Bai XM; Jiang H; Ding JX; Peng T; Ma J; Wang YH; Zhang L; Zhang H; Leng J
    Life Sci; 2010 Jan; 86(5-6):214-23. PubMed ID: 20035770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal cell-derived factor-1 enhances motility and integrin up-regulation through CXCR4, ERK and NF-kappaB-dependent pathway in human lung cancer cells.
    Huang YC; Hsiao YC; Chen YJ; Wei YY; Lai TH; Tang CH
    Biochem Pharmacol; 2007 Dec; 74(12):1702-12. PubMed ID: 17904532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 EP1 receptor enhances TGF-β1-induced mesangial cell injury.
    Chen X; Jiang D; Wang J; Chen X; Xu X; Xi P; Fan Y; Zhang X; Guan Y
    Int J Mol Med; 2015 Jan; 35(1):285-93. PubMed ID: 25352206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of integrin α3β1 expression induces proliferation and migration of non-small cell lung cancer cells.
    Yoon HJ; Cho YR; Joo JH; Seo DW
    Oncol Rep; 2013 Feb; 29(2):662-8. PubMed ID: 23233127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PGE
    Gonzalez AA; Salinas-Parra N; Leach D; Navar LG; Prieto MC
    Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1038-F1049. PubMed ID: 28701311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z; Ma J; Li N; Sun N; Wang C
    Ann Thorac Surg; 2006 Jul; 82(1):243-8. PubMed ID: 16798222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE₂-mediated activation of β-catenin signaling.
    Singh T; Katiyar SK
    PLoS One; 2013; 8(4):e60749. PubMed ID: 23580348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.